AI-Powered Microbiome Intelligence for Human Health
Alphabiome’s groundbreaking technology extracts genetic biomarkers from microbial DNA at an unprecedented scale and precision to predict the efficacy of biological and biochemical treatments.
Cracking the Genetic Code of the Microbiome
The microbiome holds immense untapped potential for predicting drug efficacy. Alphabiome’s revolutionary AI platform deciphers the previously inaccessible 99% of microbial genetic data with groundbreaking precision, identifying valuable biomarkers at unprecedented scale and unlocking new possibilities for precision medicine.
Discover Alphabiome
Learn more about how Alphabiome’s groundbreaking technology is opening new frontiers in precision medicine.
What We Do
Our Partners
25/09/2025
Validation of Alphabiome’s AI model for predicting microbiome-driven outcomes
A peer-reviewed study confirms the accuracy of Alphabiome’s AI model, validated in a controlled livestock trial assessing the methane-reducing effect of a nutritional additive.
06/05/2025
Alphabiome Unveils Revolutionary AI Technology for Microbiome Decoding
Yahoo Finance- Using proprietary algorithms and advanced modeling, Alphabiome deciphers hidden microbial DNA to accurately predict individual drug response — setting a new standard in personalized medicine.
06/05/2025
AI That Predicts Drug Response Powered by the Microbiome
Health Technolog Net- Alphabiome’s proprietary platform analyzes microbial DNA beyond reference genomes, delivering unmatched accuracy in forecasting therapeutic outcomes.
07/05/2025
Alphabiome Raises $8M to Scale Microbiome AI
Finsmes.com- Alphabiome secures seed funding to expand R&D and advance its proprietary platform for predicting drug response with greater precision.
